Skip to main content

Table 3 Results of rediscovery and similarity tasks for bridged bicyclic ring structures

From: Development of scoring-assisted generative exploration (SAGE) and its application to dual inhibitor design for acetylcholinesterase and monoamine oxidase B

Task

Target

Compound

M100

(GEGL)

M75/V20/B05

M50/V45/B05

M25/V70/B05

Rediscovery

Ingenol mebutate

0.732

0.798

0.732

0.732

Morphine

0.676

0.707

0.632

0.676

Amantadine

1.000

1.000

1.000

1.000

Rimantadine

1.000

1.000

1.000

1.000

Vildagliptin

1.000

1.000

1.000

1.000

Memantine

1.000

1.000

1.000

1.000

Tromantadine

1.000

1.000

1.000

1.000

Adapalene

1.000

1.000

1.000

1.000

Saxagliptin

1.000

1.000

1.000

1.000

Azaprophen

0.790

1.000

1.000

1.000

Psiguadial A

0.767

0.787

0.787

0.798

Similarity

Ingenol mebutate

0.976

1.000

0.976

0.893

Morphine

0.935

0.935

0.901

1.000

Amantadine

0.918

0.918

0.913

0.912

Rimantadine

1.000

1.000

1.000

1.000

Vildagliptin

1.000

1.000

1.000

1.000

Memantine

0.996

0.996

0.996

0.996

Tromantadine

1.000

1.000

1.000

1.000

Adapalene

1.000

1.000

1.000

1.000

Saxagliptin

1.000

1.000

1.000

1.000

Azaprophen

1.000

1.000

1.000

1.000

Psiguadial A

1.000

1.000

1.000

1.000

Total

20.790

21.141

20.937

21.007

  1. M is a mutate operator, V is a virtual synthesis operator, and B is a bridged bicyclic ring operator
  2. Bold value indicates the best results